Breast Cancer Clinical Trials

Showing 2021-2040 of 4,817 trials

A Study of PRT2527 in Participants With Advanced Solid Tumors

NCT05159518

This is a Phase 1 dose-escalation and confirmation study of PRT2527, a Cyclin-dependent Kinase 9 (CDK9) inhibitor, in participants with advanced solid tumors. The purpose of this study is to define the dosing schedule, and maximally tolerated dose to be used in subsequent development of PRT2527.

SarcomaCastrate Resistant Prostate CancerHormone Receptor Positive HER2 Negative Breast Cancer+2 more

Prelude Therapeutics30 participantsStarted Feb 2022

Denver, Colorado, United States • Celebration, Florida, United States • Sarasota, Florida, United States +5 more locations

UNKNOWN

A Tear-based, Lab-developed Test for Breast Cancer for Women With Dense Breast Tissue

NCT05268224

Investigation of a tear-based, lab-developed biological test for breast cancer, as a supplemental tool to current screening recommendations for women with dense breast tissue will explore if a tear-based biological test can be used as a support tool in the breast cancer screening protocol for women with dense breast tissue. The test was designed and validated by Namida Lab, Inc., a high complexity Clinical Laboratory Improvement Amendments (CLIA) certified lab.

Breast Cancer Screening

Namida Lab1,500 participantsStarted Oct 2021

Fayetteville, Arkansas, United States

A Study of PRT2527 in Participants With Advanced Solid Tumors

A Tear-based, Lab-developed Test for Breast Cancer for Women With Dense Breast Tissue

Related Searches

Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast Cancer

Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors

Evaluating Omitting of Internal Mammary Irradiation Among Early Stage Intermediate Risk (N1) Breast Cancer

Paclitaxel Plus Radiation Therapy in Treating Women With Stage II or Stage III Breast Cancer

Weight Reduction Intervention for Breast Cancer Survivors

A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors

OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults

Evaluation of Innovative Therapeutic Approaches of Vaginal and Sexual Dysfunction After Breast Cancer Treatment

A Combined Exercise Training Program for Women Living With Breast Cancer

Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m RM26

Effects of Moderate and High-intensity Exercise During Chemotherapy on Muscle Cells in Women With Breast Cancer

Breast MRI in Women With Known or Suspected Breast Cancer and in Healthy Participants

Fulvestrant With or Without Bortezomib in Patients With Inoperable Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer

Clip Marker Placement in Primary Lesions of Breast Cancer Patients Receiving Neoadjuvant Therapy

EpCAM CAR-T for Treatment of Advanced Solid Tumors

Healthy ME: Advancing Health Equity in Lymphatic Pain and Lymphedema in Black and Hispanic Women With Breast Cancer

Galunisertib and Paclitaxel in Treating Patients With Metastatic Androgen Receptor Negative (AR-) Triple Negative Breast Cancer

A Phase II Study to Explore the Safety, Tolerability, and Preliminary Antitumor Activity of Sitravatinib Plus Tislelizumab or Combination With Nab-paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)